Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
Status:
RECRUITING
Trial end date:
2029-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn about the effects of fluconazole in patients who plan to start or are currently undergoing standard of care treatment and plan to dose-escalate an IL-23 therapy for their Crohn's disease.
The main question it aims to assess is whether or not patient response to IL-23 therapies improve when simultaneously treated with fluconazole.
Phase:
PHASE3
Details
Lead Sponsor:
Weill Medical College of Cornell University
Collaborator:
The Leona M. and Harry B. Helmsley Charitable Trust